5,536
Views
4
CrossRef citations to date
0
Altmetric
Research Article

The Internet and lifestyle drugs: an analysis of demographic characteristics, methods, and motives of online purchasers of illicit lifestyle drugs in the Netherlands

&
Pages 345-355 | Received 19 Mar 2017, Accepted 17 Aug 2017, Published online: 27 Oct 2017

References

  • Aldridge, J., & Décary-Hétu, D. (2016). Hidden wholesale: The drug diffusing capacity of online drug cryptomarkets. International Journal of Drug Policy, 35, 7–15. doi:10.1016/j.drugpo.2016.04.020
  • Barratt, M.J., Ferris, J.A., & Winstock, A.R. (2014). Use of Silk Road, the online drug marketplace, in the United Kingdom, Australia and the United States. Addiction, 109, 774–783.doi:10.1111/add.12470
  • Buxton, J., & Bingham, T. (2015). The rise and challenge of dark net drug markets. Swansea: Global Drug Policy Observatory.
  • Calzo, J.P., Sonneville, K.R., Scherer, E.A., Jackson, B., & Austin, S.B. (2016). Gender conformity and use of laxatives and muscle-building products in adolescents and young adults. Pediatrics, 138, e20154073. doi:10.1542/peds.2015-4073
  • Chaudry, P., & Zimmerman, A. (2009). The economics of counterfeit trade: Governments, consumers, pirates and intellectual property right. Berlin: Springer-Verlag.
  • Cohen, J., Collins, R., Darkes, J., & Gwartney, D. (2007). A league of their own: demographics, motivations and patterns of use of 1,955 male adult nonmedical anabolic steroid users in the United States. Journal of the International Society of Sports Nutrition, 4, 1–14.doi:10.1186/1550-2783-4-12
  • Cordaro, F.G., Lombardo, S., & Cosentino, M. (2011). Selling androgenic anabolic steroids by the pound: identification and analysis of popular websites on the Internet. Scandinavian Journal of Medicine and Science in Sports, 21, 247–259.doi:10.1111/j.1600-0838.2010.01263.x
  • De Hon, O., & van Kleij, R. (2005). Kwaliteit van illegale dopingmiddelen. Een inventarisatie van de kwaliteit van illegaal verhandelde dopinggeduide middelen en de gezondheidsrisico’s bij gebruik. Capelle aan den IJssel: Nederlands Centrum voor Dopingvraagstukken.
  • Di Giorgio, (2011). Counterfeit medicines. Facts and practical advice. Milan: EDQM-AIFA.
  • Di Nicola, A., Martini, E., Baratto, G., with Antonopoulos, G.A., Boriero, D., Da Col, W., Falletta, V., … Zabyelina, Y. (2015). FAKECARE: Developing expertise against the online trade of fake medicines by producing and disseminating knowledge, counterstrategies and tools across the EU. eCrime Research Reports No.2. Trento: eCrime – University of Trento.
  • Evans-Brown, M.J., McVeigh, J., Perkins, C., & Bellis, M.A. (2012). Human enhancement drugs. The emerging challenges to public health. Liverpool: Liverpool John Moores University.
  • European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2016). European drug report 2016: Trends and developments. Luxembourg: Publications Office of the European Union.
  • Gezondheidsraad (Dutch Health Council). (2010). Dopinggebruik in de ongeorganiseerde sport. Den Haag: Gezondheidsraad.
  • Gilbert, D., Walley, T., & New, B. (2000). Lifestyle medicines. BMJ, 321, 1341–1344.doi:10.1136/bmj.321.7272.1341
  • Hall, A., & Antonopoulos, G.A. (2016). Fake meds online: The Internet and the transnational market in illicit pharmaceuticals. London: Palgrave Macmillan.
  • Intomart GfK. (2009). Geneesmiddelen op internet: een internet-onderzoek in opdracht van het ministerie van volksgezondheid. Hilversum: Intomart GfK bv.
  • Intomart (2012). Risicogedrag bij het online bestellen van geneesmiddelen. Hilversum: Intomart GfK bv.
  • Jackson, G., Arver, S., Banks, I., & Stecher, V.J. (2010). Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks. International Journal of Clinical Practice, 64, 497–504.doi:10.1111/j.1742-1241.2009.02328.x
  • Khaled, S.M., Hughes, E., Bressington, D., Zolezzi, M., Radwan, A., Badnapurkar, A., & Gray, R. (2016). The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: A systematic review protocol. Systematic Reviews, 5, 195. doi:10.1186/s13643-016-0375-5
  • Kimergård, A., McVeigh, J., Knutsson, S., Breindahl, T., & Stensballe, A. (2014). Online marketing of synthetic peptide hormones: Poor manufacturing, user safety, and challenges to public health: Online marketing of synthetic peptide hormones. Drug Testing and Analysis, 6, 396–398. doi:10.1002/dta.1636
  • Koenraadt, R.M. (2012). Blauwe pillen op de zwarte markt. Oisterwijk: Wolf Legal Publishers.
  • Koenraadt, R.M. (2015). Cultural Criminology and the Internet. Challenges for online criminological research. In: Overarching views of crime and deviancy; Rethinking the legacy of the utrecht school (pp. 547–564). The Hague: Eleven international publishers.
  • Koenraadt, R.M. (forthcoming). In pursuit of a slim and sexual body. Understanding the illicit market for lifestyle medicines. The Hague: Eleven Publishers.
  • Koenraadt, R.M., & de Haan, M. (2016). De aankoop van geneesmiddelen via internet. Een onderzoek naar het koopgedrag, de motieven, risicoperceptie en informatiebehoefte van online kopers van geneesmiddelen. Utrecht: Willem Pompe Instituut.
  • Lavorgna, A. (2015). The online trade in counterfeit pharmaceuticals: new criminal opportunities, trends and challenges. European Journal of Criminology, 12, 226–241.doi:10.1177/1477370814554722
  • Martin, J. (2014) Drugs on the dark net: How cryptomarkets are transforming the global trade in illicit drugs. London: Palgrave Macmillan.
  • Mazanov, J., Dunn, M., Connor, J., & Fielding, M.L. (2013). Substance use to enhance academic performance among Australian university students. Performance Enhancement and Health, 2, 110–118.doi:10.1016/j.peh.2013.08.017
  • McVeigh, J., Evans-Brown, M., & Bellis, M.A. (2012). Drogas potenciadoras para la búsqueda de la perfección Human enhancement drugs and the pursuit of perfection. Adicciones, 24, 185–190.
  • Monaghan, L.F. (2001). Bodybuilding, drugs and risk. Abingdon: Routledge.
  • Orsolini, L., Francesconi, G., Papanti, D., Giorgetti, A., & Schifano, F. (2015). Profiling online recreational/prescription drugs’ customers and overview of drug vending virtual marketplaces. Human Psychopharmacology: Clinical and Experimental, 30, 302–318.
  • Paoli, L., & Donati, A. (2014). The sports doping market: Understanding Supply and Demand and the Challenges of Their Control. New York: Springer.
  • Rahman, S.Z., Gupta, V., Sukhlecha, A., & Khunte, Y. (2010). Lifestyle drugs: Concept and impact on society. Indian Journal of Pharmaceutical Sciences, 72, 409. doi:10.4103/0250-474X.73902
  • Scammell, L., & Bo, A. (2016). Online supply of medicines to illicit drug markets: Situation and responses. In J. Mounteney, A. Bo, & A. Oteo (Eds.), The Internet and drug markets (pp. 107–114). Luxembourg: Publications Office if the European Union.
  • Siva, N. (2010). Tackling the booming trade in counterfeit drugs. Lancet, 376, 1725–1726.doi:10.1016/S0140-6736(10)62118-6
  • Van Hout, M.C. (2014). SMART: An Internet study of users experiences of synthetic tanning. Performance Enhancement and Health, 3, 3–14.doi:10.1016/j.peh.2014.05.001
  • Van Hout, M.C., & Bingham, T. (2013). ‘Silk Road’, the virtual drug marketplace: A single case study of user experiences. International Journal of Drug Policy, 24, 385–391.
  • Van Hout, M.C., & Brennan, R. (2014). An in-depth case examination of an exotic dancer’s experience of melanotan. The International Journal on Drug Policy, 25, 444–450.
  • Van de Ven, K. (2015). The formation and development of illicit performance and image enhancing drug markets: exploring supply and demand, and control policies in Belgium en the Netherlands [unpublished Ph.D. dissertation]. UK and NL: University of Kent and Utrecht University. Retrieved from https://kar.kent.ac.uk/54398/1/90Van%20de%20Ven%202016%20the%20PIED%20market%20University%20of%20Kent.pdf.
  • Van de Ven, K., & Mulrooney, K.J.D. (2016). Social suppliers: Exploring the cultural contours of the performance and image enhancing drug (PIED) market amongst bodybuilders in the Netherlands and Belgium. International Journal of Drug Policy, 40, 6–15. doi:10.1016/j.drugpo.2016.07.009
  • Venhuis, B.J., Zwaagstra, M.E., Van den Berg, J.D.J., Wagenaar, H.W.G., Van Riel, A.J.H., Barends, D.M., & De Kaste, D. (2009). Trends in drug substances detected in illegal weight-loss medicines and dietary supplements. RIVM Report, 1–37.
  • Venhuis, B.J., Zwaagstra, M.E., van den Berg, J.D.J., van Riel, A.J.H.P., Wagenaar, H.W.G., van Grootheest, K., … de Kaste, D. (2011). Illicit erectile dysfunction products in the Netherlands. A decade of trends and a 2007-2010 product update. Bilthoven: RIVM.
  • Wadsworth, E., Drummond, C., & Deluca, P. (2017). The adherence to UK legislation by online shops selling new psychoactive substances. Drugs: Education, Prevention and Policy, 24. doi:https://doi.org/10.1080/09687637.2017.1284417
  • Walsh, C. (2011). Drugs, the Internet and change. Journal of Psychoactive Drugs, 43, 55–63.doi:10.1080/02791072.2011.566501